-+ 0.00%
-+ 0.00%
-+ 0.00%

INOVIO PHARMACEUTICALS INC - VGX-3100 PHASE 3 TRIAL MEETS PRIMARY ENDPOINT WITH FAVORABLE SAFETY PROFILE

Reuters·05/21/2026 20:05:00

Please log in to view news